Mutations of SF3B1, MYD88, and BIRC3 did not reach statistical significance due to the low number of mutated patients at CLL diagnosis in this prospective cohort of patients (Table 1). Here, MYD88 is linked to B-cell chronic lymphocytic leukemia.